UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 293

Sortiert nach

Long-term Toxicity and Health-related Quality of Life after Single-fraction High Dose Rate Brachytherapy Boost and Hypofractionated External Beam Radiotherapy for Intermediate-risk Prostate Cancer

Clinical oncology (Royal College of Radiologists (Great Britain)), 2017-07, Vol.29 (7), p.412-420

2017

Volltextzugriff (PDF)

Does the Time of Radiotherapy Affect Treatment Outcomes? A Review of the Literature

Clinical oncology (Royal College of Radiologists (Great Britain)), 2017-04, Vol.29 (4), p.231-238

2017

Volltextzugriff (PDF)

Dexamethasone for the Prophylaxis of Radiation-induced Pain Flare after Palliative Radiotherapy for Symptomatic Bone Metastases: a Phase II Study

Clinical oncology (Royal College of Radiologists (Great Britain)), 2009-05, Vol.21 (4), p.329-335

2009

Volltextzugriff (PDF)

Two cases of acrometastasis to the hands and review of the literature

Current oncology (Toronto), 2008-10, Vol.15 (5), p.51-58

2008

Volltextzugriff (PDF)

Palliative Radiotherapy for Bone Metastases in the Last 3 Months of Life: Worthwhile or Futile?

Clinical oncology (Royal College of Radiologists (Great Britain)), 2011-12, Vol.23 (10), p.709-715

2011

Volltextzugriff (PDF)

Palliative Response and Functional Interference Outcomes Using the Brief Pain Inventory for Spinal Bony Metastases Treated with Conventional Radiotherapy

Clinical oncology (Royal College of Radiologists (Great Britain)), 2011-09, Vol.23 (7), p.485-491

2011

Volltextzugriff (PDF)

Concomitant Hypofractionated Intensity Modulated Radiation Therapy Boost For Localized High-Risk Prostate Cancer: Five-Year Results of a Prospective Trial

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.S33-S33

2016

Volltextzugriff (PDF)

EP-1432: Predicting pain response after conventional radiotherapy in 1018 patients with bone metastases

Radiotherapy and oncology, 2016-04, Vol.119, p.S665-S666

2016

Volltextzugriff (PDF)

Assessment of Health-related Quality of Life with the European Organization for Research and Treatment of Cancer QLQ-C15-PAL after Palliative Radiotherapy of Bone Metastases

Clinical oncology (Royal College of Radiologists (Great Britain)), 2012-03, Vol.24 (2), p.125-133

2012

Volltextzugriff (PDF)

An innovative rapid response radiotherapy program to reduce waiting time for palliative radiotherapy

Supportive care in cancer, 2006-01, Vol.14 (1), p.38-43

2006

Volltextzugriff (PDF)

Double-blinded, Placebo-controlled Randomized Study Evaluating the Efficacy of Risedronate to Prevent the Loss of Bone Mineral Density in Non-metastatic Prostate Cancer Patients Undergoing Radiotherapy Plus 2-3 Years of Androgen Ablation Therapy

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S42-S42

2011

Volltextzugriff (PDF)

Continued success in providing timely palliative radiation therapy at the Rapid Response Radiotherapy Program: a review of 2008-2012

Current oncology (Toronto), 2013-06, Vol.20 (3), p.e206-211

2013

Volltextzugriff (PDF)

How Accurate are Physicians' Clinical Predictions of Survival and the Available Prognostic Tools in Estimating Survival Times in Terminally III Cancer Patients? A Systematic Review

Clinical Oncology, 2001-06, Vol.13 (3), p.209-218

2001

Volltextzugriff (PDF)

Concomitant Hypofractionated IMRT Boost for High-Risk Prostate Cancer: 5 Year Results

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S106-S106

2013

Volltextzugriff (PDF)

Fatigue Scores in Patients With Brain Metastases Receiving Whole Brain Radiation Therapy

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S90-S90

2013

Volltextzugriff (PDF)

Ondansetron rapidly dissolving film for the prophylactic treatment of radiation-induced nausea and vomiting-a pilot study

Current oncology (Toronto), 2015-06, Vol.22 (3), p.199-210

2015

Volltextzugriff (PDF)

A Survey of Expectations and Understanding of Palliative Radiotherapy from Patients with Advanced Cancer

Clinical oncology (Royal College of Radiologists (Great Britain)), 2012-03, Vol.24 (2), p.134-138

2012

Volltextzugriff (PDF)

Aprepitant and granisetron for the prophylaxis of radiotherapy-induced nausea and vomiting after moderately emetogenic radiotherapy for bone metastases: a prospective pilot study

Current oncology (Toronto), 2014-12, Vol.21 (6), p.e760-767

2014

Volltextzugriff (PDF)

How much does Gleason grade of follow-up biopsy differ from that of initial biopsy in untreated, Gleason score 4-7, clinically localized prostate cancer?

The Prostate, 2007-11, Vol.67 (15), p.1614-1620

2007

Volltextzugriff (PDF)

Patterns of practice in the prescription of palliative radiotherapy for the treatment of bone metastases at the Rapid Response Radiotherapy Program between 2005 and 2012

Current oncology (Toronto), 2013-10, Vol.20 (5), p.e396-405

2013

Volltextzugriff (PDF)

A Re-analysis Of Symptom Clusters In Advanced Cancer Patients Using Three Statistical Methods

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S651-S651

2011

Volltextzugriff (PDF)

Dexamethasone Toxicity and Quality of Life in Patients with Brain Metastases Treated with Whole Brain Radiotherapy

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S671-S671

2011

Volltextzugriff (PDF)

Prevalence of Sleep Disturbance in Patients with Bone Metastases Attending an Outpatient Radiotherapy Clinic

International journal of radiation oncology, biology, physics, 2010, Vol.78 (3), p.S581-S581

2010

Volltextzugriff (PDF)

Patient Reported Outcomes after Hypofractionated Radiotherapy and Long-term Androgen Deprivation for High-risk Prostate Cancer

International journal of radiation oncology, biology, physics, 2010, Vol.78 (3), p.S345-S345

2010

Volltextzugriff (PDF)

The Edmonton Symptom Assessment Scale (ESAS) as a Prognostic Indicator for Impending Death in Advanced Cancer Patients Referred for Palliative Radiotherapy

International journal of radiation oncology, biology, physics, 2010, Vol.78 (3), p.S68-S68

2010

Volltextzugriff (PDF)

1 – 25 von 293

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(276)
Mit Volltextzugriff
(262)

Publikationsform

Artikel
(292)
magazinearticle
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(146)
Science & Technology
(136)
Life Sciences & Biomedicine
(135)
Male
(100)
Oncology
(83)
Aged
(81)
Middle Aged
(81)
Female
(75)
Biological And Medical Sciences
(70)
Medical Sciences
(68)
Aged, 80 And Over
(55)
Adult
(54)
Hematology, Oncology And Palliative Medicine
(48)
Radiology
(45)
Radiology, Nuclear Medicine & Medical Imaging
(44)
Radiotherapy
(40)
Prospective Studies
(37)
Palliative Care
(23)
Bone Neoplasms - Secondary
(22)
Treatment Outcome
(21)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term Toxicity and Health-related Quality of Life after Single-fraction High Dose Rate Brachytherapy Boost and Hypofractionated External Beam Radiotherapy for Intermediate-risk Prostate Cancer

Does the Time of Radiotherapy Affect Treatment Outcomes? A Review of the Literature

Dexamethasone for the Prophylaxis of Radiation-induced Pain Flare after Palliative Radiotherapy for Symptomatic Bone Metastases: a Phase II Study

Two cases of acrometastasis to the hands and review of the literature

Palliative Radiotherapy for Bone Metastases in the Last 3 Months of Life: Worthwhile or Futile?

Palliative Response and Functional Interference Outcomes Using the Brief Pain Inventory for Spinal Bony Metastases Treated with Conventional Radiotherapy

Concomitant Hypofractionated Intensity Modulated Radiation Therapy Boost For Localized High-Risk Prostate Cancer: Five-Year Results of a Prospective Trial

EP-1432: Predicting pain response after conventional radiotherapy in 1018 patients with bone metastases

Assessment of Health-related Quality of Life with the European Organization for Research and Treatment of Cancer QLQ-C15-PAL after Palliative Radiotherapy of Bone Metastases

An innovative rapid response radiotherapy program to reduce waiting time for palliative radiotherapy

Double-blinded, Placebo-controlled Randomized Study Evaluating the Efficacy of Risedronate to Prevent the Loss of Bone Mineral Density in Non-metastatic Prostate Cancer Patients Undergoing Radiotherapy Plus 2-3 Years of Androgen Ablation Therapy

Continued success in providing timely palliative radiation therapy at the Rapid Response Radiotherapy Program: a review of 2008-2012

How Accurate are Physicians' Clinical Predictions of Survival and the Available Prognostic Tools in Estimating Survival Times in Terminally III Cancer Patients? A Systematic Review

Concomitant Hypofractionated IMRT Boost for High-Risk Prostate Cancer: 5 Year Results

Fatigue Scores in Patients With Brain Metastases Receiving Whole Brain Radiation Therapy

Ondansetron rapidly dissolving film for the prophylactic treatment of radiation-induced nausea and vomiting-a pilot study

A Survey of Expectations and Understanding of Palliative Radiotherapy from Patients with Advanced Cancer

Aprepitant and granisetron for the prophylaxis of radiotherapy-induced nausea and vomiting after moderately emetogenic radiotherapy for bone metastases: a prospective pilot study

How much does Gleason grade of follow-up biopsy differ from that of initial biopsy in untreated, Gleason score 4-7, clinically localized prostate cancer?

Patterns of practice in the prescription of palliative radiotherapy for the treatment of bone metastases at the Rapid Response Radiotherapy Program between 2005 and 2012

A Re-analysis Of Symptom Clusters In Advanced Cancer Patients Using Three Statistical Methods

Dexamethasone Toxicity and Quality of Life in Patients with Brain Metastases Treated with Whole Brain Radiotherapy

Prevalence of Sleep Disturbance in Patients with Bone Metastases Attending an Outpatient Radiotherapy Clinic

Patient Reported Outcomes after Hypofractionated Radiotherapy and Long-term Androgen Deprivation for High-risk Prostate Cancer

The Edmonton Symptom Assessment Scale (ESAS) as a Prognostic Indicator for Impending Death in Advanced Cancer Patients Referred for Palliative Radiotherapy

Suchergebnisse filtern